Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration

Kevin Zarrabi1, Antoine Dufour, Jian Li

  • 1Department of Medicine/Cancer Prevention, Stony Brook University, Stony Brook, New York 11794, USA.

Insights

Matrix metalloproteinase-14 (MMP-14) drives cancer metastasis via its hemopexin domain. Novel peptides targeting this domain inhibit metastasis without affecting tumor growth, offering a new therapeutic strategy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Matrix metalloproteinases (MMPs) facilitate extracellular matrix remodeling and cell migration, crucial for cancer metastasis.
  • MMP-14, a membrane-anchored MMP, is particularly implicated in these metastatic processes.
  • The hemopexin (PEX) domain of MMP-14 is hypothesized to mediate cell migration through MMP-14 homodimerization and heterodimerization with CD44.

Purpose of the Study:

  • To identify the minimal functional regions within the MMP-14 PEX domain responsible for cell migration.
  • To investigate the role of specific PEX domain regions in MMP-14 homodimerization and CD44 heterodimerization.
  • To develop and evaluate peptide inhibitors targeting the MMP-14 PEX domain for anti-metastatic therapy.

Main Methods:

  • Site-directed mutagenesis to probe functional regions within the MMP-14 PEX domain.
  • Analysis of MMP-14 homodimerization and CD44 heterodimerization.
  • Design and synthesis of peptides mimicking critical PEX domain motifs.
  • In vitro assays to assess peptide inhibition of MMP-14-enhanced cell migration and metastasis models.

Main Results:

  • Mutagenesis identified Blades I and IV of the PEX domain as critical for cell migration.
  • Blade IV is essential for MMP-14 homodimerization, while Blade I is required for CD44-MMP-14 heterodimerization.
  • MMP-14/CD44 cross-talk activates EGF receptor, MAPK, and PI3K signaling pathways.
  • Synthetic peptides targeting the PEX domain effectively inhibited MMP-14-mediated cell migration and metastasis in a dose-dependent manner.
  • These peptides demonstrated efficacy against metastasis without impacting primary tumor growth.

Conclusions:

  • The MMP-14 PEX domain contains essential regions (Blades I and IV) critical for mediating cancer cell migration and metastasis.
  • Targeting the MMP-14 PEX domain with specific peptide inhibitors represents a promising and selective strategy to combat cancer dissemination.
  • This approach offers a novel therapeutic avenue for inhibiting metastasis without compromising primary tumor development.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...